Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

eslicarbazepine

eslicarbazepine
  • Formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Aptiom TABLET, ORAL 200 mg, 800 mg      
Aptiom TABLET, ORAL 400 mg, 600 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

eslicarbazepine (Aptiom)

  • 400 mg tablet oral
  • 600 mg tablet oral

eslicarbazepine (Aptiom)

  • TWO 200 mg tablets (Total: 400 mg)
  • THREE 200 mg tablets (Total: 600 mg)

Aptiom Medication Guide

Reviewed: May 27, 2014

Last updated: Jun. 28, 2022
  • HAZ-MED: Group 3
  • Formulary, Not Routinely Stocked: Aptiom --> 400 mg tablet, 600 mg tablet






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved